NCBI PubMed Central
open access
Berbamine hydrochloride as a brain-penetrant galectin-3 inhibitor in a model of Huntington's disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Consistency of Serial CSF alpha-Synuclein Seed Amplification Assay Results in the Parkinson's Progression Marker Initiative#150420
- Hyphenated Mass Spectrometry-based Strategies for Characterizing Oligomers of alpha-Synuclein in Parkinson’s Disease#241329
- Small molecules to perform big roles : The search for Parkinson's and Huntington's disease therapeutics#270317
- Design and Development of Peptide Inhibitors Targeting Alpha-Synuclein for Parkinson’s Disease#246148
- Selective vulnerability of monoaminergic neurons and network spread of alpha-synuclein jointly explain pathology progression in Parkinson's disease models.#305237
Record · ID 1204466
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive